Tianjin Medical University Cancer Institute and Hospital

Last updated

[1] [2] [3] [4]


The hospital was established in 1861 with the name of London Christian Church Hospital. Jin Xianzhai, the well-known oncologist, set up the first tumor ward in the hospital in 1952. In 1972, the hospital became a specialized cancer hospital with 341 beds. In 1977, the Institute of Cancer Research was established with eight departments. The institute is dedicated to cancer research, treatment, and prevention. The institute was established by Professor Jin Xianzhai, a prominent Chinese oncologist, it originated as the Cancer Prevention Research Laboratory within Tianjin People's Hospital. Over the years, it has evolved and expanded its scope, eventually becoming a significant player in the field of oncology.


Since its inception the Tianjin Medical University Cancer Institute and Hospital (TMUCIH) has played a pivotal role in advancing medical expertise in the field of oncology and pathology. Tasked by the Ministry of Health, the institute took the lead in initiating the "Advanced National oncologists and Pathologists Training Course," a significant endeavor aimed at nurturing specialized professionals in the battle against cancer. Tianjin Medical University Cancer Institute and Hospital is one of the largest bases for cancer prevention, treatment, training and research in China. Tianjin Medical University Cancer Institute and Hospital (TMUCIH) strives to provide the best treatment in China to cancer patients and is one of the largest cancer centers in China, with 2319 beds, 46 clinical and diagnostic departments and 13 research departments.

Cancer prevention and treatment research center

Tianjin Medical University is constructing the largest cancer prevention, treatment, and research base in Asia.[ citation needed ] On June 27, 1989[ when? ] construction of the comprehensive cancer prevention and treatment research center, with a gross floor area of 93,000 square meters, started at Tianjin Medical University Cancer Institute and Hospital. Upon completion, the hospital will have 1,800 beds, be able to serve 500,000 outpatients, and perform over 20,000 surgical operations annually.

In 2017, Oncology was ranked as the National "world class" Academic Development by the Ministry of Education, Ministry of Finance and the National Development and reform commission.


The hospital has about 1.3 million visits and 32,000 surgeries every year. The cancer institute has 12 departments; Cancer Epidemiology & Biostatistics Laboratory, the Pathology Laboratory, the Biochemistry & Molecular Biology Laboratory, the Cancer Cell Biology Laboratory, the Immuno-Biotechnology Laboratory, the Gastrointestinal Tumor Biology Laboratory, the Pharmacology Laboratory, the Public Laboratory, the Tumor Molecular Diagnostic Center, the Tissue Bank, the Library and the Editorial Department. - Throughout its history, the Institute has been under the leadership of distinguished figures in the field. Successive directors include Jin Xianzhai, Zhou Yanchang, Zhang Tianze, and Jin Jiarui. Currently, the Institute is led by Academician Hao Xishan, who serves as the director. Assisting in this role are three deputy directors: Professor Ying Guoguang, Professor Niu Ruifang, and Professor Li Hui.

Quick Facts

The Main Campus of the Hospital has a land space of 69,000m2 and building area of 175,052m2. As of 2018, there have been 1,224,629 outpatient visits and 103,123 in-patient visits. As of 2019, there are 2,319 beds and a staff of 2,968 employees. There are in total 3 locations of the Tianjin Medical Institute including the main campus, Airport Free Trade Zone Hospital, and the Binhai Hospital.

Future Breakthroughs

The hospital will become the largest cancer prevention, treatment and research base in Asia, incorporating fundamental oncological research, clinical treatment and high-end training. Their Motto is "To provide patients with the uttermost integrity and state of the art medicine. To improve our profession with integrity and innovations".

The center plans to make a breakthrough in integrating clinical treatment and scientific research; seven clinical research centers will be constructed, with a view to realizing a "seamless interconnection" between clinical treatment and scientific research.

Related Research Articles

The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.

<span class="mw-page-title-main">Tianjin Medical University</span> Public medical university in Tianjin, China

Tianjin Medical University is a municipal public medical university in Tianjin, China. It is affiliated with the City of Tianjin, and co-funded by the Tianjin Municipal People's Government, the National Health Commission, and the Ministry of Education. The university is part of Project 211 and the Double First-Class Construction.

<span class="mw-page-title-main">James Ewing (pathologist)</span> American pathologist

James Stephen Ewing was an American pathologist. He was the first Professor of pathology at Cornell University and discovered a form of bone cancer that was later named after him, Ewing sarcoma.

Shaukat Khanum Memorial Cancer Hospital and Research Centre(Urdu: یادگاری اسپتالِ شوکت خانم برائے معالجہ و تحقیقِ سرطان, abbreviated as SKMCH&RC/SKMCH) is a cancer centre with locations in Lahore and Peshawar, Pakistan. It is the first project of the Shaukat Khanum Memorial Trust, a charitable organization established under the Societies Registration Act XXI of 1858 of British India. It is Pakistan's largest tertiary care hospital.

M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.

<span class="mw-page-title-main">St. Vincent's Medical Center Riverside</span> Hospital in Florida, United States

In 1916, the Daughters of Charity of Saint Vincent de Paul launched a Catholic hospital called St. Vincent's Medical Center Riverside. They provide full-service tertiary care at a capacity of 528 beds.

<span class="mw-page-title-main">David Khayat</span> French oncologist

David Khayat is a French oncologist. Head of the Department of Medical Oncology at the Pitié-Salpêtrière Hospital since 1990, he is also Professor of oncology at the University Pierre and Marie Curie and adjunct Professor at the MD Anderson Cancer Center in Houston, Texas. He was elected at the American Society of Clinical Oncology board in 2013. Organiser of the World Summit against Cancer at the UNESCO, he initiated the Charter of Paris against Cancer and headed the French Cancer National Institute between April 2004 and September 2006. He is its Honorary President now. Professor Khayat is the founder and the President of the Foundation AVEC, a non-profit organisation declared of public utility since 2013 . He also became a consultant for various industries in the 2010s; in particular, he is paid by Philip Morris International for a lobbying activity in favor of heated tobacco product.

<span class="mw-page-title-main">Uppsala University Hospital</span> Hospital in Uppsala, Sweden

Uppsala University Hospital in Uppsala, Sweden, is a teaching hospital for the Uppsala University Faculty of Medicine and the Nursing School. Uppsala University Hospital is owned and operated by the Uppsala County Council in cooperation with the university and serves, together with Enköping hospital in Enköping, as the primary hospitals for Uppsala County. It also fills the function of a tertiary referral hospital for the Uppsala/Örebro health care region and, for certain specialities, a tertiary referral hospital for the entire country of Sweden.

Rakesh K. Jain is the Andrew Werk Cook Professor of Tumor Biology at Massachusetts General Hospital in the Harvard Medical School and director of the E.L. Steele Laboratories for Tumor Biology at the Massachusetts General Hospital.

James Lewis Abbruzzese is the Chief of the Duke Division of Medical Oncology and associate director for Clinical Research for the Duke Cancer Institute. Previously, Abbruzzese was Chairman of the Department of Gastrointestinal Medical Oncology at the University of Texas M. D. Anderson Cancer Center where he held the M. G. and Lillie A. Johnson Chair for Cancer Treatment and Research and the Annie Laurie Howard Research Distinguished Professorship. Abbruzzese is one of the world's leaders in the clinical study and treatment of pancreatic cancer.

<span class="mw-page-title-main">Kunming Medical University</span> Medical school in Kunming, China

Kunming Medical University, previously known as Kunming Medical College, is a medical school located in Kunming City, Yunnan Province, China.

<span class="mw-page-title-main">King Hussein Cancer Foundation and Center</span> Hospital in Amman, Jordan

The King Hussein Cancer Foundation (KHCF) and Center (KHCC) ,an independent Jordanian non-governmental, non-profit institution. It was established in 2001 by a royal decree issued and is led by Princess Ghida Talal. The Foundation's mission is to combat cancer through awareness, prevention, and early detection programs, providing comprehensive care for cancer patients from Jordan and the Arab world, in addition to promoting research and innovation.

<span class="mw-page-title-main">Oncology</span> Branch of medicine dealing with, or specializing in, cancer

Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:

Professor Minesh P. Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.

<span class="mw-page-title-main">Japanese Foundation for Cancer Research</span> Japanese non-profit organization

The Japanese Foundation for Cancer Research (公益財団法人がん研究会) (JFCR) is a non-profit cancer research organization based in Ariake, Tokyo. The JFCR was founded in 1908 as the first Japanese organization specializing in cancer by Katsusaburō Yamagiwa and his supporters. The Cancer Institute and its attached hospital of JFCR were set up in 1934. The JFCR became a full member of the Union for International Cancer Control in 1968.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore, MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country.

<span class="mw-page-title-main">Sun Yat-sen University Cancer Center</span> Hospital in Guangzhou, China

Sun Yat-sen University Cancer Center, abbreviated as SYSUCC, is a public hospital in Guangzhou, China. It is affiliated with Sun Yat-sen University.

<span class="mw-page-title-main">Hyen-taik Kimm</span> Chinese oncologist (1904–1990)

Hyen-taik Kimm was a Korean-Chinese physician that specialized in oncology. In China, he is remembered as the "Father of Chinese Oncology" for his many pioneering contributions to the field in the country as a researcher, educator, and practitioner. He was the first oncologist in China, created the first Chinese oncology journal, the Chinese Journal of Clinical Oncology, and the first Chinese oncologist organization, the Anti-Cancer Society of China.

Magnus von Knebel Doeberitz is a molecular oncologist and virologist, a professor of molecular oncology and medical director of the Department of Applied Tumor Biology at the Institute of Pathology at the University Hospital of Heidelberg. He also heads a Clinical Cooperation at the German Cancer Research Center.

<span class="mw-page-title-main">Soma Sengupta</span> Scientist and neuro-oncologist

Soma Sengupta is a British-American physician-scientist. She is a specialty board certified neuro-oncologist board certified Neurologist, fellowship-trained in Integrative Medicine. Her clinical interests span treatment of brain tumor patients, integrative approaches in neurology and oncology, as well as healthcare policy. She is a full-time faculty member in the Departments of Neurology and Neurosurgery at the University of North Carolina at Chapel Hill, where she is a Full Professor, Vice Chair, and Chief of the Division of Neuro-Oncology. She is also a Bye Fellow at Lucy Cavendish College, University of Cambridge, U.K.


  1. "TMUCIH About Us".
  2. "Cancer Biology and Medicine".
  3. "Tianjin Medical University Cancer Institute & Hospital".
  4. "Tianjin Medical University Cancer Institute & Hospital".